Literature DB >> 7902331

The relative contribution of antibodies, CD4+ and CD8+ T cells to sporozoite-induced protection against malaria.

M Rodrigues1, R S Nussenzweig, F Zavala.   

Abstract

Protective immunity against Plasmodium yoelii, induced by sporozoite immunization, was investigated using a quantitative method based on the measurement of plasmodial ribosomal RNA in the liver of sporozoite-challenged mice. The relative importance of the different immune mechanisms induced by sporozoite immunization was determined by evaluating quantitatively the anti-parasite activity of antibodies, CD4+ and CD8+ T cells. The role of antibodies was determined by passive transfer of immune sera to naive mice. The transfer to mice of sera obtained after a single immunizing dose reduced the liver stages by 47%. The respective contribution of CD4+ and CD8+ T-cell subsets was determined in B10 (H-2b) mice, treated with a monoclonal antibody (mAb) which inhibits B-cell maturation, and subsequently immunized once with irradiated sporozoites. These mice produced low levels of anti-sporozoite antibodies, but were capable of inhibiting the development of liver stages as efficiently as non-manipulated immunized mice. Administration of either anti-CD4 or anti-CD8 mAb to these mice, did not significantly decrease their capacity to inhibit the development of liver stages. We only observed a significant loss of immunity when the mice were depleted in vivo of both CD4+ and CD8+ T cells. In contrast to earlier studies, we found that the induction of protective immunity is not a phenomenon restricted to a few strains of mice having a particular genetic make-up. The apparent non-responsiveness observed in some strains of mice can be overcome by using larger immunizing doses.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7902331      PMCID: PMC1422124     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Specific inflammatory cell infiltration of hepatic schizonts in BALB/c mice immunized with attenuated Plasmodium yoelii sporozoites.

Authors:  Z M Khan; J P Vanderberg
Journal:  Int Immunol       Date:  1992-07       Impact factor: 4.823

Review 2.  The circumsporozoite protein of Plasmodium: a mechanism of immune evasion by the malaria parasite?

Authors:  L Schofield
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

Review 3.  The multifactorial character of the protective immunity induced by immunization with sporozoites.

Authors:  F Zavala
Journal:  Res Immunol       Date:  1991-10

4.  Plasmodium yoelii: quantification of the exoerythrocytic stages based on the use of ribosomal RNA probes.

Authors:  G Arreaza; V Corredor; F Zavala
Journal:  Exp Parasitol       Date:  1991-01       Impact factor: 2.011

5.  In vitro activity of CD4+ and CD8+ T lymphocytes from mice immunized with a synthetic malaria peptide.

Authors:  L Rénia; M S Marussig; D Grillot; S Pied; G Corradin; F Miltgen; G Del Giudice; D Mazier
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-15       Impact factor: 11.205

6.  CD8+ cytolytic T cell clones derived against the Plasmodium yoelii circumsporozoite protein protect against malaria.

Authors:  M M Rodrigues; A S Cordey; G Arreaza; G Corradin; P Romero; J L Maryanski; R S Nussenzweig; F Zavala
Journal:  Int Immunol       Date:  1991-06       Impact factor: 4.823

7.  Use of attenuated sporozoites in the immunization of human volunteers against falciparum malaria.

Authors:  K H Rieckmann; R L Beaudoin; J S Cassells; K W Sell
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

8.  Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.

Authors:  D Herrington; J Davis; E Nardin; M Beier; J Cortese; H Eddy; G Losonsky; M Hollingdale; M Sztein; M Levine
Journal:  Am J Trop Med Hyg       Date:  1991-11       Impact factor: 2.345

9.  Monoclonal, but not polyclonal, antibodies protect against Plasmodium yoelii sporozoites.

Authors:  Y Charoenvit; S Mellouk; C Cole; R Bechara; M F Leef; M Sedegah; L F Yuan; F A Robey; R L Beaudoin; S L Hoffman
Journal:  J Immunol       Date:  1991-02-01       Impact factor: 5.422

10.  Protection against malaria by vaccination with sporozoite surface protein 2 plus CS protein.

Authors:  S Khusmith; Y Charoenvit; S Kumar; M Sedegah; R L Beaudoin; S L Hoffman
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

View more
  34 in total

1.  Complete, long-lasting protection against malaria of mice primed and boosted with two distinct viral vectors expressing the same plasmodial antigen.

Authors:  O Bruña-Romero; G González-Aseguinolaza; J C Hafalla; M Tsuji; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

2.  Assessment of antibody protection against malaria sporozoites must be done by mosquito injection of sporozoites.

Authors:  Jerome Vanderberg; Ann-Kristin Mueller; Kirsten Heiss; Kristin Goetz; Kai Matuschewski; Martina Deckert; Dirk Schlüter
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

3.  Immunization of mice with live-attenuated late liver stage-arresting Plasmodium yoelii parasites generates protective antibody responses to preerythrocytic stages of malaria.

Authors:  Gladys J Keitany; Brandon Sack; Hannah Smithers; Lin Chen; Ihn K Jang; Leslie Sebastian; Megha Gupta; D Noah Sather; Marissa Vignali; Ashley M Vaughan; Stefan H I Kappe; Ruobing Wang
Journal:  Infect Immun       Date:  2014-09-29       Impact factor: 3.441

4.  Chemically attenuated Plasmodium sporozoites induce specific immune responses, sterile immunity and cross-protection against heterologous challenge.

Authors:  Lisa A Purcell; Kurt A Wong; Stephanie K Yanow; Moses Lee; Terry W Spithill; Ana Rodriguez
Journal:  Vaccine       Date:  2008-07-29       Impact factor: 3.641

5.  Why functional pre-erythrocytic and bloodstage malaria vaccines fail: a meta-analysis of fully protective immunizations and novel immunological model.

Authors:  D Lys Guilbride; Pawel Gawlinski; Patrick D L Guilbride
Journal:  PLoS One       Date:  2010-05-19       Impact factor: 3.240

Review 6.  A retrospective evaluation of the role of T cells in the development of malaria vaccine.

Authors:  Moriya Tsuji
Journal:  Exp Parasitol       Date:  2009-11-26       Impact factor: 2.011

7.  Class II-restricted protective immunity induced by malaria sporozoites.

Authors:  Giane A Oliveira; Kota Arun Kumar; J Mauricio Calvo-Calle; Caroline Othoro; David Altszuler; Victor Nussenzweig; Elizabeth H Nardin
Journal:  Infect Immun       Date:  2007-12-26       Impact factor: 3.441

8.  Protective immunity induced by daily bites from irradiated mosquitoes infected with Plasmodium yoelii.

Authors:  K A Wong; A Zhou; A Rodriguez
Journal:  Parasite Immunol       Date:  2008-09       Impact factor: 2.280

9.  Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.

Authors:  Chandy C John; Aaron J Tande; Ann M Moormann; Peter O Sumba; David E Lanar; Xinan M Min; James W Kazura
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

Review 10.  Antigens for pre-erythrocytic malaria vaccines: building on success.

Authors:  C Speake; P E Duffy
Journal:  Parasite Immunol       Date:  2009-09       Impact factor: 2.280

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.